Department of Cellular and Molecular Biology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
Auto-generated profile, based on publicly available information
Hossein Abbasinia
Department of Cellular and Molecular Biology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
Root canal therapy is a predominant method for treatment of dental pulp and periapical diseases. Conventional methods such as mechanical instrumentations, chemical irrigation and intracanal medicaments pose a huge limitation to root canal disinfection as they kill bacteria and dental stem cells simultaneously. Therefore, much attention has been focused on finding more efficacious antibacterial methods that has no or negligible cytotoxicity for dental stem cells. Herein, we hypothesized that combining antibacterial medicaments with Antimicrobial photodynamic therapy (aPDT) and methylene blue (MB) as a photosensitizer would be effective in reducing death of dental pulp stem cells (DPSCs). To examine this, DPSCs were isolated from third molar teeth through enzymatic digestion. Isolated cells were cultured in αMEM and when reached adequate confluency, were used for further analysis. Cytotoxicity effect of different groups of MB, DAP, MB, LED and their combination on DPSCs was analyzed using MTT assay. DPSCs membrane integrity as a marker of live cells was assessed through measuring lipid peroxidation and lactate dehydrogenase (LDH) release into extracellular space. Results showed that the combination of LED, MB and TAP or aPDT, MB and DAP was more effective in reducing DPSCs death rate compared to TAP and DAP administration alone. Moreover, Malondialdehyde (MDA) and LDH levels were found to be decreased in cells exposed to combination treatment in comparison with single TAP or DAP therapy. Our study shows the promising perspectives of employing combined aPDT, MB and antibiotic medicaments for reduction of dental stem cell death.
1 January 2021 in Journal of lasers in medical sciences
Introduction: Cancer is one of the most important problems in the world. Low-level laser therapy (LLLT) has been emerged as a new approach, having both stimulation and inhibition effects on cellular function. The goal of this study was to analyze and compare the different concentrations of cisplatin and wavelengths of laser therapy on the LnCap cell lines. Methods: LnCap cells were cultured and treated with different concentrations of cisplatin (0.1, 0.4, 0.8, 1.2 and 2 µg/mL for 24 hours) and wavelengths of laser therapy (610, 630 and 810 nm) (0.45 J/cm2 ) separately. The viability of cells was examined by MTT assay and IC50 was also calculated. Furthermore, a combination of cisplatin IC50 (24 hours) and different wavelengths of the laser was examined. Results: The results of this study showed that 2 µg/mL of cisplatin has the most significant reduction effect on the cell viability of the LnCap cell line. Cisplatin decreased the viability of cells in a dose-dependent manner. Moreover, IC50 of cisplatin was 1.24 µg/mL. On the other hand, LLLT with wavelengths of 610, 630 and 810 nm did not show notable biological effects on cell viability. Conclusion: As known, cisplatin has the capability to reduce the viability of LnCap cell lines. However, LLLT cannot be a remarkable option for the treatment of prostate cancer. Therefore, although laser therapy showed praiseful therapeutic activity against some cancer cell lines, in this study the results indicated that defined laser wavelengths had no inhibitory effects against the prostate cancer cell line.
7 September 2025 in Biochemistry and Biophysics Reports
Dual inhibition of extracellular signal-regulated kinase (MEK) and transforming growth factor beta (TGFβ), known as R2i, sustains ground-state pluripotency in mouse embryonic stem cells (mESCs). To understand the molecular mechanisms of R2i, we analyzed the proteomic profile of mESCs cultured under R2i conditions in our previous study. Our data showed overexpression of the cell cycle and apoptosis regulator 1 (Ccar1) under R2i conditions. In this study, we investigated the role of Ccar1 in the pluripotency of mESCs through the loss-of-function approach. We hypothesize that Ccar1 contributes to the maintenance of pluripotency by interacting with β-catenin and preventing its translocation to the nucleus. Therefore, we used siRNA against Ccar1 and then analyzed the localization of β-catenin and the expression of its target genes by immunofluorescence assay and qRT-PCR. Immunofluorescence analysis demonstrated that siRNA-mediated downregulation of Ccar1 promoted the nuclear translocation of β-catenin. qRT-PCR analysis showed a significant reduction of pluripotency marker genes as well as some cell cycle markers such as Ccar1, c-myc, and Tbx3 in siRNA-treated cells. In addition, the expression level of the Wnt target genes (Cdx1, Wnt3a, Tbx1, Fgf4, Apc, Cdh1, Wnt3a) was significantly increased when Ccar1 was knocked down. We observed that upregulation of Ccar1 under R2i culture conditions could prevent nuclear translocation of β-catenin and maintain pluripotency and self-renewal of mESCs. These findings suggest that Ccar1 prevents nuclear β-catenin translocation to maintain pluripotency and self-renewal of mESCs under R2i conditions, although further direct interaction assays are required to confirm this mechanism.